🇺🇸 FDA
Pipeline program

Fp/ABS

FpA-AS-30093

Phase 3 small_molecule active

Quick answer

Fp/ABS for Asthma is a Phase 3 program (small_molecule) at Teva Pharma GmbH with 1 ClinicalTrials.gov record(s).

Program details

Company
Teva Pharma GmbH
Indication
Asthma
Phase
Phase 3
Modality
small_molecule
Status
active

Clinical trials